In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...

Obesity directly affects kidney health and influences chronic kidney disease (CKD) risk and progression through contributing ...

Weight-loss jabs are “not the holy grail”, the NHS medical director has said. Prof Sir Stephen Powis said the drugs would be ...

The number of U.S. children who suffer seizures after swallowing prescription medications or illicit drugs has doubled in ...

Experts reevaluate coverage policies and the financial impact of antiobesity medications based on updated clinical data and ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies say this will limit patient access.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Studies show that people with obesity are more likely to find that ill health affects their productivity and attendance at work.

A weight-loss drug more effective than Ozempic and Wegovy has recently been approved. Here’s how it works and how it compares ...

ROACH: I am 5 feet, 1 inch tall, weigh 200 pounds, and have found it next to impossible to lose weight, even though I'm active. I swim, walk, or do yoga almost every day. I avoid most processed foods ...

A woman who takes weight loss medication has called Health Secretary Wes Streeting “naive” after he suggested weight-loss jabs could be given to unemployed people to help them return to the workplace.